Cibenzoline - Toa Eiyo
Alternative Names: TY-0305Latest Information Update: 07 Jun 2022
At a glance
- Originator Toa Eiyo
- Class Antiarrhythmics; Cardiovascular therapies; Class I antiarrhythmics
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Hypertrophic cardiomyopathy
Most Recent Events
- 18 Sep 2019 Phase-II clinical trials in Hypertrophic cardiomyopathy in Japan (PO) (JapicCTI194910)